DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 30 Sep 2026. Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be r…
Opportunity overview
- Project name
- DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
- Donor
- Defense Health Agency Contracting Activity - DHACA
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award?
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 30 Sep 2026. Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be r…
Who is funding DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award?
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award is funded by Defense Health Agency Contracting Activity - DHACA.
When is the deadline to apply for DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award?
The application deadline is 30 Sep 2026 00:00 (UTC).
Where will the DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award project take place?
The project location(s) are: United States.
How can I apply for DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.